Jabodon PT Co’s ICU Medical ICUI Stock Holding History

Jabodon PT Co’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,253	Closed	-$2.42M	–	27
2020 Q3	$2.42M	Buy	+13,253	New	+$2.5M	2.14%	14

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Jabodon PT Co's ICUI Position: Q4 2020 in Review

Jabodon PT Co sold out of ICU Medical (ICUI) in Q4 2020, closing a stake of 13,253 shares — an estimated $2.42M sold.

Jabodon PT Co first reported a position in ICUI in Q3 2020 and held it in 1 quarter. The position peaked at $2.42M in Q3 2020. 284 funds tracked by Wall St. Rank hold ICUI as of Q4 2020.

Jabodon PT Co reported no remaining ICU Medical position as of Q4 2020 after selling out during the quarter.
Jabodon PT Co sold 13,253 ICU Medical shares in Q4 2020, an estimated $2.42M.
Jabodon PT Co first reported a position in ICU Medical in Q3 2020 and held it in 1 quarter.
Jabodon PT Co's ICU Medical position peaked at $2.42M in Q3 2020.
284 funds tracked by Wall St. Rank held ICU Medical as of Q4 2020.

Based on Jabodon PT Co's 13F filing for Q4 2020, filed 3 Feb 2021.